Cabozantinib: Uses, Mechanism & Side Effects
Cabozantinib is a targeted cancer therapy used to treat certain malignant tumors by blocking signals that drive tumor growth and spread.
Things worth knowing about "Cabozantinib"
Cabozantinib is a targeted cancer therapy used to treat certain malignant tumors by blocking signals that drive tumor growth and spread.
What is Cabozantinib?
Cabozantinib is a tyrosine kinase inhibitor (TKI) belonging to the class of targeted cancer therapies. It works by blocking multiple proteins involved in tumor growth and blood vessel formation. The drug is marketed under the brand names Cabometyx and Cometriq and is taken orally, either as a tablet or capsule.
Indications
Cabozantinib has been approved by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) for the following conditions:
- Renal cell carcinoma (RCC): as first- or second-line therapy, including in combination with the immunotherapy agent nivolumab
- Hepatocellular carcinoma (HCC): liver cancer previously treated with sorafenib
- Medullary thyroid cancer (MTC): a rare, aggressive form of thyroid cancer
- Differentiated thyroid cancer (DTC): after failure of radioiodine therapy in progressive disease
Mechanism of Action
Cabozantinib simultaneously inhibits multiple receptor tyrosine kinases -- enzymes that transmit signals controlling cell growth and survival. Key targets include:
- MET (hepatocyte growth factor receptor): promotes tumor growth and metastasis
- VEGFR-1, -2, -3 (vascular endothelial growth factor receptors): regulate the formation of new blood vessels in the tumor (angiogenesis)
- RET: frequently mutated in medullary thyroid cancer
- AXL and KIT: involved in tumor immunology and resistance mechanisms
By blocking these pathways simultaneously, cabozantinib cuts off the tumor's blood supply, reduces its capacity to spread (metastasize), and promotes cancer cell death (apoptosis).
Dosage and Administration
The dosage depends on the specific indication and the formulation used:
- Cabometyx (tablets): typically 60 mg once daily for kidney and liver cancer; 40 mg when combined with nivolumab
- Cometriq (capsules): 140 mg daily for medullary thyroid cancer
The medication should be taken on an empty stomach. Grapefruit juice and certain other drugs can alter its effectiveness and should be avoided during treatment.
Side Effects
Like all tyrosine kinase inhibitors, cabozantinib can cause a range of side effects. The most common include:
- Diarrhea, nausea, and vomiting
- Hand-foot syndrome (redness, pain, and blistering on the palms and soles)
- Fatigue and weakness
- High blood pressure (hypertension)
- Weight loss and decreased appetite
- Elevated liver enzyme levels
- Impaired wound healing, and rarely fistula formation or gastrointestinal perforation
Serious side effects such as bleeding events, thromboembolic events, or liver toxicity require close medical monitoring and may necessitate dose reductions or discontinuation of treatment.
Important Warnings
Cabozantinib is contraindicated during pregnancy and breastfeeding, as it may harm the unborn child. Women of childbearing potential must use effective contraception during treatment and for at least four months after the last dose. The therapy is always administered under regular oncological supervision.
References
- European Medicines Agency (EMA): Cabometyx - Summary of Product Characteristics. Available at: https://www.ema.europa.eu
- Choueiri TK et al. - Cabozantinib plus Nivolumab versus Sunitinib in Advanced Renal-Cell Carcinoma. New England Journal of Medicine, 2021; 384:829-840.
- Abou-Alfa GK et al. - Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma (CELESTIAL). New England Journal of Medicine, 2018; 379:54-63.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryLactic acid
Lorlatinib
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Cabozantinib